News

Ahead of World Malaria Day, Target Malaria, a not-for-profit research consortium pioneering genetic technologies for malaria ...
The detection of dark matter, the elusive type of matter predicted to make up most of the universe's mass, is a long-standing ...
Dr. Jeffrey Nickle, a cybersecurity researcher and U.S. Army combat-disabled veteran, has introduced TTAT+—Technology Threat Avoidance Theory Plus—as an evolved framework for assessing, modeling, and ...
ViroCell Biologics ("ViroCell" or the "Company"), a specialist viral vector Contract Development and Manufacturing ...
Monument Therapeutics, a precision-neuroscience company focused on the development of innovative treatments for serious central nervous system disorders (CNS), today announced two key leadership ...
Norgine is pleased to announce that the Australian Therapeutic Goods Administration (TGA) has approved the registration of IFINWIL® (eflornithine) for the treatment of adults and paediatric patients ...